ROMWELL, Conn. — Culturelle is launching Culturelle Baby, a new line of probiotics formulated for children up to 24 months.

The i-Health Inc. brand said Culturelle Baby is aimed at helping young children develop a healthy microbiome — the bacteria that live mainly inside the digestive system — during the first two years of life, which can set the foundation for their healthy growth and development.

The line includes Culturelle Baby Calm + Comfort and Culturelle Baby Grow + Thrive. Culturelle Baby products contain Lactobacillus rhamnosus GG (LGG), the most clinically studied probiotic strain in infants, and are free of GMOs, gluten, dairy and dyes, according to Culturelle.

Culturelle Baby Calm + Comfort probiotic drops with chamomile help reduce crying and fussiness from occasional digestive upset by restoring the balance of healthy bacteria in a baby’s digestive system, the company said. Culturelle Baby Grow + Thrive contains LGG and Bifidobacterium lactis BB-12 probiotic strains to help support the healthy development of a baby’s digestive and immune systems. It supplements the good bacteria naturally found in breast milk and contains vitamin D for strong bones.

Culturelle said Baby Calm + Comfort and Culturelle Baby Grow + Thrive come in drop form and can be dispensed directly into the baby’s mouth, bottle or while breastfeeding for newborns up to 12 months. Grow + Thrive is also available as a flavorless packet that can be mixed into cold or room-temperature food or drinks for babies 12 to 24 months.

“New parents have enough to think about when it comes to creating a healthy foundation for their newborn. Culturelle Baby gives them the peace of mind that comes with a clinically studied probiotic strain, in an easy-to-use format,” stated Nicole Bourdeau, senior brand manager for Culturelle Kids and Baby. “That way, parents can spend more time enjoying their baby’s other milestones in those first few years.”

Culturelle Baby probiotics, with a suggested retail price of $25.99, are available now at Amazon.com and are slated to roll our to major retail stores — including Walmart, Target, CVS Pharmacy and Walgreens — beginning in January.